PeptideTreatments
Reviewed by Peptide Treatments Medical Advisory Board

Oxytocin: Research & Evidence

Established Evidence

Published research, clinical trial data, and evidence grading for Oxytocin across studied indications.

Back to Oxytocin overview

Research Summary

Oxytocin has been used in obstetrics since the 1980s with 1,000+ human studies and 100+ obstetric RCTs. A PPH prevention trial (n=15,000, PMID: 22649381) demonstrated 30% reduction in blood loss. The off-label CNS evidence is more mixed: a single-dose study (n=55, PMID: 23593097) showed improved social cognition in ASD adults, but a chronic dosing trial (n=68, PMID: 28297628) found no significant effect in children. Multiple RCTs for autism, PTSD, and social anxiety are ongoing. The gap between the robust physiology of oxytocinergic signaling and consistent therapeutic outcomes for CNS indications remains the key challenge.

Evidence by Indication (4 indications)

Indication Tier Trials Summary
Labor induction and augmentation Tier A 100 Standard of care for decades; definitive RCT evidence
Postpartum hemorrhage prevention Tier A 50 Cochrane review confirms 30% blood loss reduction
Autism (social deficits) Tier C 10 Mixed results — single-dose benefit vs no chronic dosing effect
PTSD and social anxiety Tier D 5 Limited observational and small RCT data; ongoing trials

Graded using our evidence tier methodology.

Research Gap Score /10

Higher score = larger gap between therapeutic potential and available clinical evidence.

Citations (4 sources)

  1. 1. Oxytocin induction of labor: a randomized controlled trial Clinical Trial

    Bugg GJ, Siddiqui F, Thornton JG (2009), BJOG

  2. 2. Prophylactic oxytocin for the third stage of labour Review

    Westhoff G, Cotter AM, Tolosa JE (2012), Cochrane Database

  3. 3. Intranasal oxytocin improves social cognition in autism Clinical Trial

    Andari E, Duhamel JR, Zalla T, et al. (2013), PNAS

  4. 4. Chronic intranasal oxytocin and social responsiveness in children with autism Clinical Trial

    Yatawara CJ, Einfeld SL, Hickie IB, et al. (2017), Molecular Psychiatry